Industry

Results from the study showed adults and children aged 13 and older with uncontrolled asthma using the ProAir Digihaler and its integrated system had 85.3% higher odds of improving their asthma control after three months compared with those using standard of care albuterol inhalers Physicians reported more interactions with patients on poor inhaler technique based … [Read more…]

Individuals with memory problems encouraged to learn more about study MATTHEWS, N.C.–(BUSINESS WIRE)–AMC Research is initiating a clinical trial for a promising new investigational treatment for Alzheimer’s disease (AD) in Matthews, N.C. The Phase I study will determine the safety and tolerability of a single intravenous (IV) dose and multiple IV doses of ACU193. We … [Read more…]

BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will participate in the Morgan Stanley 20th Annual Global Healthcare Conference taking place September 12-14, 2022 in New York City. Corey McCann, M.D., Ph.D., President and CEO, will participate in a fireside … [Read more…]

More than 126 employees to ride in the company’s annual Coast 2 Coast 4 Cancer ride through towns and cities between the Oregon Coast and the New Jersey shore PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #C2C4C–Bristol Myers Squibb employees will embark on a cross-country bike ride from the coast of Oregon to honor loved ones who have been … [Read more…]

PITTSBURGH–(BUSINESS WIRE)–Carmell Therapeutics, a pioneering company in the development and commercialization of innovative Plasma-based Bioactive Materials (PBMs) to accelerate bone and soft tissue healing, today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed public listing of its Class … [Read more…]

CAMBRIDGE, Mass. & MONTREAL–(BUSINESS WIRE)–Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that members of its senior management team will participate at two investor conferences in September. Details for the fireside chats are as follows: Morgan Stanley 20th Annual Global Healthcare Conference Date: Wednesday, September 14, … [Read more…]

New leaders will focus on making clinical trials more efficient and accessible ATLANTA–(BUSINESS WIRE)–Florence Healthcare™ announced today that it has hired two key opinion leaders as part of its mission to make clinical trials more efficient and accessible. Kristin Surdam, MS, PMP, CCRC, will lead the company’s thought leadership team and efforts to engage sponsors … [Read more…]

ROCKVILLE, Md.–(BUSINESS WIRE)–GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that Harout Semerjian, Chief Executive Officer, will present in-person at the H.C. Wainwright 24th Annual Global Investment Conference in New York, NY on Wednesday, September 14, 2022 at 3:00 p.m. ET. An archived recording of the presentation will be available for 90 days on the GlycoMimetics website … [Read more…]

MANCHESTER, England–(BUSINESS WIRE)–Manchester United and global wellness technology leader, Therabody have deepened their relationship by becoming global partners in a multi-year agreement. The partnership will expand Manchester United’s use of Therabody products and solutions as part of the training and recovery regimes of both the men’s and women’s teams – and showcase their benefits to … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced that their previously mentioned Advance Safety Needle System™ has entered full scale production on their automated machine. The Advance needle was tested in 2021, has been used in Kurin accounts since last year and is now widely available. “We … [Read more…]